Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: A systematic review

European Journal of Contraception and Reproductive Health Care

Volumn 17, Issue 4, 2012, Pages 245-253

  Warholm, Lina ^a   Petersen, Kresten R ^b   Ravn, Pernille ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Body composition; Bone mineral density; Combined oral contraceptives; Height; Weight; Young girls

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE GROWTH; BONE MINERAL; FEMALE; HIGH RISK PATIENT; HUMAN; LEAN BODY WEIGHT; LOW DRUG DOSE; OBESITY; ORAL CONTRACEPTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; WEIGHT CHANGE; WEIGHT GAIN;

ADOLESCENT; AGE FACTORS; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CONTRACEPTIVES, ORAL, COMBINED; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; WEIGHT GAIN;

EID: 84863860490     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2012.692411     Document Type: Review

References (37)

1. The reproductive health report: The state of sexual.nd reproductive health within the European Union. Eur J Contracept Reprod Health Care 2011;16(Suppl. 1):S1-70.
2. Lara-Torre E. Update in adolescent contraception. Obstet Gynecol Clin North Am 2009;36:119-28.
3. Krishnamoorthy N, Simpson CD, Townend J, et al. Adolescent females and hormonal contraception: A retrospective study in primary care. J Adolesc Health 2008;42:97-101. (Pubitemid 350284604)
4. Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: Effects on weight. Cochrane Database Syst Rev 2008;(4):CD003987.
5. Brill K. Minimizing the problem of poor compliance in adolescents. Clinical experience with a modern lowdose gestodene-containing oral contraceptive. Ann N Y Acad Sci 1997;816:457-65. (Pubitemid 27346214)
6. Berenson AB, Wiemann CM, Rickerr VI, McCombs SL. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use. Am J Obstet Gynecol 1997;176:586-92. (Pubitemid 27147166)
7. Berenson AB, Wiemann CM. Use of levonorgestrel implants versus oral contraceptives in adolescence: A case-control study. Am J Obstet Gynecol 1995;172:1128-35.
8. Risser WL, Gefter LR, Barratt MS, Risser JM. Weight change in adolescents who used hormonal contraception. J Adolesc Health 1999;24:433-6. (Pubitemid 29283357)
9. Bonny AE, Ziegler J, Harvey R, et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006;160:40-5. (Pubitemid 43042133)
10. Beksinska ME, Smit JA, Kleinschmidt I, et al. Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception. Contraception 2010;81:30-4.
11. Bonny AE, Secic M, Cromer BA. A longitudinal.omparison of body composition changes in adolescent girls receiving hormonal contraception. J Adolesc Health 2009;45:423-5.
12. Lloyd T, Lin HM, Matthews AE, et al. Oral.ontraceptive use by teenage women does not affect body composition. Obstet Gynecol 2002;100:235-9. (Pubitemid 34874783)
13. Lloyd T, Petit MA, Lin HM, Beck TJ. Lifestyle factors and the development of bone mass and bone strength in young women. J Pediatr 2004;144:776-82. (Pubitemid 38858096)
14. Lloyd T, Taylor DS, Lin HM, et al. Oral contraceptive use by teenage women does not affect peak bone mass: A longitudinal study. Fertil Steril 2000;74:734-8.
15. Tolaymat LL, Kaunitz AM. Use of hormonal contraception in adolescents: Skeletal health issues. Curr Opin Obstet Gynecol 2009;21:396-401.
16. Herrmann M, Seibel MJ. The effects of hormonal contraceptives on boneturnover markers and bone health. Clin Endocrinol (Oxf) 2010;72:571-83.
17. Agostino H, Di MG. Low-dose oral contraceptives in adolescents: How low can you go? J Pediatr Adolesc Gynecol 2010;23:195-201.
18. Martins SL, Curtis KM, Glasier AF. Combined hormonal contraception and bone health: A systematic review. Contraception 2006;73:445-69.
19. Pikkarainen E, Lehtonen-Veromaa M, Mottonen T, et al.Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: A 4-year follow-up study. Contraception 2008;78:226-231.
20. Beksinska ME, Kleinschmidt I, Smit JA, Farley TM. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception. Contraception 2007;75:438-43. (Pubitemid 46766652)
21. Beksinska ME, Kleinschmidt I, Smit JA, Farley TM. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraception 2009;79:345-9.
22. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 2004;35:434-41. (Pubitemid 39576013)
23. Scholes D, Hubbard RA, Ichikawa LE, et al. Oral contraceptive use and bone density change in adolescent and young adult women: A prospective study of age, hormone dose, and discontinuation. J Clin Endocrinol Metab 2011;96:E1380-E1387.
24. Holmes BL, Ludwa IA, Gammage KL, et al. Relative importance of body composition, osteoporosis-related behaviors, and parental income on bone speed of sound in adolescent females. Osteoporos Int 2010;21:1953-7.
25. Klentrou P, Ludwa IA. Quantitative bone ultrasound measurements in young females 14-23 years of age. J Womens Health (Larchmt) 2011;20:677-83.
26. Cromer BA, Blair JM, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996;129:671-6. (Pubitemid 27498275)
27. Cromer BA, Bonny AE, Stager M, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: A 24-month prospective study. Fertil Steril 2008;90:2060-7.
28. Lara-Torre E, Edwards CP, Perlman S, Hertweck SP. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 2004;17:17-21. (Pubitemid 38315009)
29. Scholes D, Ichikawa L, LaCroix AZ, et al. Oral contraceptive use and bone density in adolescent and young adult women. Contraception 2010;81:35-40.
30. Lattakova M, Borovsky M, Payer J, Killinger Z. Oral contraception usage in relation to bone mineral density and boneturnover in adolescent girls. Eur J Contracept Reprod Health Care 2009;14:207-14.
31. Laveissiere MN, Pelissier C, Le MG. La contraception orale en France en 2001: Résultats d'une enquête par sondage portant sur 3609 femmes âgées de 15 à 45 ans. [Oral contraception in France in 2001: Results of an opinion poll survey conducted on 3609 women between 15 and 45]. Gynecol Obstet Fertil 2003;31:220-9. (Pubitemid 36735439)
32. Hamani Y, Sciaki-Tamir Y, Deri-Hasid R, et al.Misconceptions about oral contraception pills among adolescents and physicians. Hum Reprod 2007;22:3078-83. (Pubitemid 351696767)
33. American College of Obstetricians and Gynecologists. Safety of oral contraceptives for teenagers. J Adolesc Health 1992;13:333-6.
34. Biro FM, Huang B, Crawford PB, et al. Pubertal correlates in black and white girls. J Pediatr 2006;148:234-40. (Pubitemid 43292239)
35. Ward KA, Adams JE, Mughal MZ. Bone status during adolescence, pregnancy and lactation. Curr Opin Obstet Gynecol 2005;17:435-9. (Pubitemid 41044416)
36. Wasnich RD, Miller PD. Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 2000;85:231-6. (Pubitemid 32268819)
37. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002;359:1841-50. (Pubitemid 34607063)